During the past decade, St. Luke's Hematology Oncology Specialists conducted 2 clinical trials. In the 10-year time frame, 2 clinical trials started and 1 clinical trials were completed, i.e. on average, 50% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 1 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

According to Clinical.Site data, the most researched conditions in "St. Luke's Hematology Oncology Specialists" are "Advanced Breast Cancer" (1 trials), "Early Breast Cancer" (1 trials) and "Metastatic Breast Cancer" (1 trials). Many other conditions were trialed in "St. Luke's Hematology Oncology Specialists" in a lesser frequency.

Most popular intervention types in "St. Luke's Hematology Oncology Specialists" are "Drug" (1 trials) and "Other" (1 trials). Other intervention types were less common.

The name of intervention was led by "TALAZOPARIB" (1 trials) and "non-interventional" (1 trials). Other intervention names were less common.

The vast majority of trials in "St. Luke's Hematology Oncology Specialists" are 2 trials for "All" genders.

Currently, there are NaN active trials in "St. Luke's Hematology Oncology Specialists". undefined are not yet recruiting, undefined are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 1 completed trials in St. Luke's Hematology Oncology Specialists, undefined suspended trials, and 1 terminated clinical trials to date.

Out of the total trials that were conducted in St. Luke's Hematology Oncology Specialists, 0 "Phase 1" clinical trials were conducted, 1 "Phase 2" clinical trials and 0 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".